IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 11 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $113,000 | +5550.0% | 19,830 | +1883.0% | 0.00% | – |
| Q4 2017 | $2,000 | -90.0% | 1,000 | -84.1% | 0.00% | – |
| Q2 2017 | $20,000 | -37.5% | 6,288 | -16.8% | 0.00% | – |
| Q1 2017 | $32,000 | +433.3% | 7,558 | +277.9% | 0.00% | – |
| Q4 2016 | $6,000 | -40.0% | 2,000 | -20.0% | 0.00% | – |
| Q3 2016 | $10,000 | +150.0% | 2,500 | +147.3% | 0.00% | – |
| Q1 2016 | $4,000 | -42.9% | 1,011 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | – | 1,011 | +5847.1% | 0.00% | – |
| Q2 2015 | $0 | – | 17 | +6.2% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 16 | -99.1% | 0.00% | – |
| Q4 2014 | $13,000 | 0.0% | 1,696 | -4.2% | 0.00% | – |
| Q3 2014 | $13,000 | +550.0% | 1,771 | +410.4% | 0.00% | – |
| Q2 2014 | $2,000 | -71.4% | 347 | -65.8% | 0.00% | – |
| Q1 2014 | $7,000 | – | 1,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|